ProHance 279.3 mg/mL (Gadoteridol INJECTION, SOLUTION) 279.3 mg/mL

ProHance 279.3 mg/mL is a gadoteridol injection used for magnetic resonance imaging (MRI) contrast enhancement. This solution aids in improving the clarity of MRI scans, helping healthcare professionals visualize internal structures more effectively.

Strength

279.3 mg/mL

Pack Size

5 VIAL, PHARMACY BULK PACKAGE in 1 BOX (0270-1111-70) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE

Manufacturer / TM Owner

Bracco Diagnostics Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ProHance 279.3 mg/mL is primarily used as a contrast agent in MRI procedures. It helps to enhance the visibility of certain tissues and structures within the body, making it easier to detect abnormalities. This gadoteridol injection is often utilized in diagnostic imaging to improve the accuracy of MRI scans.

Side Effects

When administered intravenously, ProHance 279.3 mg/mL works by temporarily altering the magnetic properties of certain tissues, which can enhance the contrast in MRI images. This can lead to clearer and more detailed images, aiding in the diagnosis of various conditions.

Precautions & Warnings

ProHance 279.3 mg/mL should be used with caution in individuals with a history of allergic reactions to gadolinium-based contrast agents. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the solution.

Avoid Interactions

ProHance 279.3 mg/mL may interact with certain medications or medical conditions. It is advisable to consult with a healthcare provider to ensure it is safe for use, especially if you are taking other medications or have pre-existing health issues.

Frequently Asked Questions

ProHance 279.3 mg/mL is used as a contrast agent in MRI procedures to enhance the visibility of internal structures.

ProHance 279.3 mg/mL is administered intravenously by a healthcare professional during an MRI scan.

ProHance 279.3 mg/mL works by temporarily altering the magnetic properties of tissues, enhancing the contrast in MRI images.

Yes, it should be used with caution in individuals with a history of allergic reactions to gadolinium-based contrast agents.

It may interact with certain medications or medical conditions, so it is important to consult with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.